骨代谢标记在接受脏移植的人群中的潜在作用
Flávia Maria Borges Vigil1,2, Pedro Alves Soares Vaz de Castro1, Ursula Gramiscelli Hasparyk1
1Interdisciplinary Laboratory of Medical Investigation, Unit of Pediatric Nephrology, Faculty of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Current medicinal chemistry
|February 9, 2024
概括
与血液透析相比,移植显著降低了骨代谢标志物,改善了矿物质和骨疾病. 这些标记物的小组还预测了移植受体的高血症和脂质失调症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 生物化学 生化学
背景情况:
- 矿物质和骨疾病 (MBD) 在移植后很常见,受免疫抑制和甲状腺功能障碍的影响.
- 虽然MBD的风险因素已知,但它们对骨代谢生物标志物的影响需要进一步研究.
- 这项研究比较了移植患者,血液透析患者和健康个体的骨代谢生物标志物.
研究的目的:
- 研究移植对骨代谢生物标志物的影响.
- 为了将这些生物标志物与脏移植接受者,血液透析患者和健康对照者进行比较.
- 评估骨生物标志物的预测价值,以评估移植受体中高热血症和脂质失调症的预测值.
主要方法:
- 一项横截面研究包括57名脏移植接受者,26名血液透析患者和31名健康对照.
- 测量了Dickkopf相关蛋白1的血度,骨质保护素,骨质卡尔辛,骨质,硬质和纤维细胞生长因子23.
- 分析了生物标志物和临床/实验室数据之间的关联.
主要成果:
- 与血液透析患者相比,移植接受者显示所有测量的骨代谢生物标志物的水平明显较低.
- 性酸酶与骨质素正相关,纤维细胞生长因子23与25-基维生素D负相关.
- 一个由骨生物标志物组成的小组有效地预测了移植受体的高血症 (AUC=0.852) 和脂质失调症 (AUC=0.811).
结论:
- 移植显著调节MBD标志物,改善末期病患者的骨代谢.
- 与迪克科普相关的蛋白1的水平降低,骨质保护素,骨质素,骨质素和硬质素表明移植后骨健康得到改善.
- 骨生物标记面板可以预测移植患者的高血症和脂质失调症.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
01:31Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
01:22Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
01:25Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K